Abstract

SM17, a new IL-17RB-targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call